'Twenty-nine different Car-T treatments for autoimmune diseases, ranging from the muscle inflammation condition myositis to multiple sclerosis, are now being tested in clinical trials by drugmakers including Novartis and Bristol Myers Squibb'
#Immunology #Autoimmunity #CARTcells
https://www.ft.com/content/a974f4c1-bb8a-4a1b-9d88-a2cf14be5c6e